Weekly and monthly regimens of paclitaxel and carboplatin in the management of advanced ovarian cancer. A preliminary report on side effects
- 29 July 2001
- journal article
- clinical trial
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 11 (4) , 295-299
- https://doi.org/10.1046/j.1525-1438.2001.011004295.x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Carboplatin and paclitaxel in ovarian carcinoma: a phase I study of the Gynecologic Oncology Group.Journal of Clinical Oncology, 1996
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cell lung cancer.Journal of Clinical Oncology, 1994
- Paclitaxel administered by 1-hour infusion. Preliminary results of a phase 1/11 trial comparing two schedulesCancer, 1994
- Primary treatment of epithelial ovarian malignanciesCancer, 1993
- Neurotoxic side-effects of cisplatinEuropean Journal of Cancer and Clinical Oncology, 1991
- Cisplatin nephrotoxicityCancer Chemotherapy and Pharmacology, 1989
- A Comparison of the Toxicity and Efficacy of Cisplatin and Carboplatin in Advanced Ovarian CancerActa Oncologica, 1989
- AnnouncementGynecologic Oncology, 1986
- Carboplatin: the clinical spectrum to dateCancer Treatment Reviews, 1985